Valera Pharmaceuticals Inc (VLRX)

Ticker: VLRX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
458.05
Quantity 66,682 +18.7%
Value US$3,182,464
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
157.87
Quantity 59,026 -8.5%
Value US$3,901,955
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
69.53
Quantity 70,855 +21.7%
Value US$438,327
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
8.45
Quantity 400 -2.6%
Value US$3,380
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
8.23
Quantity 333 -9.2%
Value US$2,741
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
8.30
Quantity 9,000 -71.2%
Value US$74,700
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Sale
Price
8.31
Quantity 4,000 -24.0%
Value US$33,240
Silverman Howard Non-Executive Director
Transaction date
Purchase
Price
7.90
Quantity 5,000 +50.0%
Value US$39,500
Tierney David S President and CEO Executive Director
Transaction date
Purchase
Price
7.73
Quantity 1,000 +18.2%
Value US$7,730
Silverman Howard Non-Executive Director
Transaction date
Purchase
Price
9.13
Quantity 10,000 +inf%
Value US$91,300
Kuzma Petr F VP, Research and Development Officer
Transaction date
Purchase
Price
9.00
Quantity 1,100 +inf%
Value US$9,900
HUCKEL HUBERT E MD Non-Executive Director
Transaction date
Purchase
Price
9.00
Quantity 3,300 +inf%
Value US$29,700
Perron Pete VP, Sales Officer
Transaction date
Purchase
Price
9.00
Quantity 500 +inf%
Value US$4,500
Drechsler Andrew T Chief Financial Officer Officer
Transaction date
Purchase
Price
9.00
Quantity 1,600 +inf%
Value US$14,400
Tierney David S President and CEO Executive Director
Transaction date
Purchase
Price
9.00
Quantity 5,500 +inf%
Value US$49,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
66,682 +18.7%
458.05
US$3,182,464
66,682 +18.7% 458.05 US$3,182,464
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
59,026 -8.5%
157.87
US$3,901,955
59,026 -8.5% 157.87 US$3,901,955
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
70,855 +21.7%
69.53
US$438,327
70,855 +21.7% 69.53 US$438,327
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
400 -2.6%
8.45
US$3,380
400 -2.6% 8.45 US$3,380
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
333 -9.2%
8.23
US$2,741
333 -9.2% 8.23 US$2,741
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
9,000 -71.2%
8.30
US$74,700
9,000 -71.2% 8.30 US$74,700
2007-02-28 2007-02-26 S Sale HUCKEL HUBERT E MD Non-Executive Director
4,000 -24.0%
8.31
US$33,240
4,000 -24.0% 8.31 US$33,240
2006-05-25 2006-05-25 B Purchase Silverman Howard Non-Executive Director
5,000 +50.0%
7.90
US$39,500
5,000 +50.0% 7.90 US$39,500
2006-05-25 2006-05-25 B Purchase Tierney David S

President and CEO

Executive Director
1,000 +18.2%
7.73
US$7,730
1,000 +18.2% 7.73 US$7,730
2006-05-08 2006-05-04 B Purchase Silverman Howard Non-Executive Director
10,000 +inf%
9.13
US$91,300
10,000 +inf% 9.13 US$91,300
2006-02-02 2006-02-02 B Purchase Kuzma Petr F

VP, Research and Development

Officer
1,100 +inf%
9.00
US$9,900
1,100 +inf% 9.00 US$9,900
2006-02-02 2006-02-02 B Purchase HUCKEL HUBERT E MD Non-Executive Director
3,300 +inf%
9.00
US$29,700
3,300 +inf% 9.00 US$29,700
2006-02-02 2006-02-02 B Purchase Perron Pete

VP, Sales

Officer
500 +inf%
9.00
US$4,500
500 +inf% 9.00 US$4,500
2006-02-02 2006-02-02 B Purchase Drechsler Andrew T

Chief Financial Officer

Officer
1,600 +inf%
9.00
US$14,400
1,600 +inf% 9.00 US$14,400
2006-02-02 2006-02-02 B Purchase Tierney David S

President and CEO

Executive Director
5,500 +inf%
9.00
US$49,500
5,500 +inf% 9.00 US$49,500
Explore more

More insider trading research around Valera Pharmaceuticals Inc